Cargando…

The surgical management of women with ovarian cancer in the south west of England

The surgical management of epithelial ovarian cancer in the South West of England was studied in the two years 1997–1998 in order to determine the factors that influence the outcome of surgery and to provide a baseline from which to assess the effect of centralisation of cancer services. All hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Olaitan, A, Weeks, J, Mocroft, A, Smith, J, Howe, K, Murdoch, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364011/
https://www.ncbi.nlm.nih.gov/pubmed/11747321
http://dx.doi.org/10.1054/bjoc.2001.2196
Descripción
Sumario:The surgical management of epithelial ovarian cancer in the South West of England was studied in the two years 1997–1998 in order to determine the factors that influence the outcome of surgery and to provide a baseline from which to assess the effect of centralisation of cancer services. All hospitals in the South West region of England participating in the Regional Cancer Organisation's longitudinal study of outcomes in gynaecological malignancies are included. Six hundred and eighty-two patients with epithelial ovarian cancer were registered with the RCO in the two-year study period. Five hundred and ninety-five women were offered primary cytoreductive surgery of which 438 were said to be optimally cytoreduced. Applying multivariate models to analyse the outcome of surgery, older patients (OR = 0.82 per 5-year increase in age, P = 0.0003), patients treated in hospitals managing fewer than ten cases of ovarian cancer per year (OR = 1.92, P = 0.02) and patients with FIGO stage 3 (OR = 0.02, P < 0.0001) or 4 (OR = 0.002, P < 0.0001) disease were less likely to be optimally cytoreduced. Gynaecological oncologists were 2.06 times more likely to attain optimal cytoreduction when compared to general gynaecologists and this was statistically significant (P = 0.01). The results from this study support the argument that limiting surgery for ovarian malignancy to specialised surgeons improves the extent of cytoreductive surgery. © 2001 Cancer Research Campaign http://www.bjcancer.com